MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples

References

• Waddington CH. Genetic assimilation of the bithorax phenotype. Evolution. 1956;10(1):1–13.
   Web of Science ®Google Scholar
• Dawson Mark A, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12–27.
   PubMed Web of Science ®Google Scholar
• Skene PJ, Henikoff S. Histone variants in pluripotency and disease. Development. 2013;140(12):2513–2524.
   PubMed Web of Science ®Google Scholar
• Caprioli RM, Farmer T, Fau - Gile J, et al. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 1997;69 (23):4751–4760.
   PubMed Web of Science ®Google Scholar
• Luger K, Mader AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 1997;389(6648):251–260.
   PubMed Web of Science ®Google Scholar
• Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature. 2003;423(6936):145–150.
   PubMed Web of Science ®Google Scholar
• Izzo A, Kamieniarz K, Schneider R. The histone H1 family: specific members, specific functions? Biol Chem. 2008;389(4):333–343.
   PubMed Web of Science ®Google Scholar
• Song F, Chen P, Sun D, et al. Cryo-EM study of the chromatin fiber reveals a double helix twisted by tetranucleosomal units. Science. 2014;344(6182):376–380.
   PubMed Web of Science ®Google Scholar
• Harshman SW, Young NL, Parthun MR, et al. H1 histones: current perspectives and challenges. Nucleic Acids Res. 2013;41(21):9593–9609.
   PubMed Web of Science ®Google Scholar
• Vignali M, Workman JL. Location and function of linker histones. Nat Struct Biol. 1998;5(12):1025–1028.
   PubMedGoogle Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41–45.
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074–1080.
   PubMed Web of Science ®Google Scholar
• Dion MF, Altschuler SJ, Wu LF, et al. Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci U.S.A. 2005;102(15):5501–5506.
   PubMed Web of Science ®Google Scholar
• Masri S, Patel VR, Eckel-Mahan KL, et al. Circadian acetylome reveals regulation of mitochondrial metabolic pathways. Proc Natl Acad Sci. 2013;110(9):3339–3344.
   PubMed Web of Science ®Google Scholar
• Peleg S, Sananbenesi F, Zovoilis A, et al. altered histone acetylation is associated with age-dependent memory impairment in mice. Science. 2010;328(5979):753–756.
   PubMed Web of Science ®Google Scholar
• Taipale M, Rea S, Richter K, et al. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol. 2005;25(15):6798–6810.
   PubMed Web of Science ®Google Scholar
• Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 2007;76(1):75–100.
   PubMed Web of Science ®Google Scholar
• Musselman CA, Lalonde M-E, Cote J, et al. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol. 2012;19(12):1218–1227.
   PubMed Web of Science ®Google Scholar
• Taverna SD, Li H, Ruthenburg AJ, et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007;14(11):1025–1040.
   PubMed Web of Science ®Google Scholar
• Kamakaka RT, Biggins S. Histone variants: deviants? Genes Dev. 2005;19(3):295–316.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hoover ME, Dang X, et al. Quantitative mass spectrometry reveals that intact histone H1 phosphorylations are variant specific and exhibit single molecule hierarchical dependence. Mol Cell Proteomics. 2015 Jul 24. pii: mcp.M114.046441. [Epub ahead of print].
   Google Scholar
• Hergeth SP, Schneider R. The H1 linker histones: multifunctional proteins beyond the nucleosomal core particle. EMBO Rep. 2015;16(11):1439–1453.
   PubMed Web of Science ®Google Scholar
• Kim YZ. Altered histone modifications in gliomas. Brain Tumor Res Treat. 2014;2(1):7–21.
   PubMedGoogle Scholar
• Fullgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene. 2011;30(31):3391–3403.
   PubMed Web of Science ®Google Scholar
• Ye J, Ai X, Eugeni EE, et al. Histone H4 lysine 91 acetylation: a core domain modificationassociated with chromatin assembly. Mol Cell. 2005;18(1):123–130.
   PubMed Web of Science ®Google Scholar
• Zhang L, Eugeni E, Parthun M, et al. Identification of novel histone post-translational modifications by peptide mass fingerprinting. Chromosoma. 2003;112(2):77–86.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Garcia BA. Comprehensive catalog of currently documented histone modifications. Cold Spring Harb Perspect Biol. 2015;7(9):a025064.
   PubMed Web of Science ®Google Scholar
• Thorslund T, Ripplinger A, Hoffmann S, et al. Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage. Nature. 2015;527(7578):389–393.
   PubMed Web of Science ®Google Scholar
• Hu J, Donahue G, Dorsey J, et al. H4K44 acetylation facilitates chromatin accessibility during meiosis. Cell Rep. 2015;13(9):1772–1780.
   PubMed Web of Science ®Google Scholar
• Feng Y, Jankovic J, Wu YC. Epigenetic mechanisms in Parkinson’s disease. J Neurol Sci. 2015;349(1–2):3–9.
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37(4):391–400.
   PubMed Web of Science ®Google Scholar
• Waldmann T, Schneider R. Targeting histone modifications–epigenetics in cancer. Curr Opin Cell Biol. 2013;25(2):184–189.
   PubMed Web of Science ®Google Scholar
• Wang J, Yu JT, Tan MS, et al. Epigenetic mechanisms in Alzheimer’s disease: implications for pathogenesis and therapy. Ageing Res Rev. 2013;12(4):1024–1041.
   PubMed Web of Science ®Google Scholar
• Zhang Q-J, Liu Z-P. Histone methylations in heart development, congenital and adult heart diseases. Epigenomics. 2015;7(2):321–330.
   PubMed Web of Science ®Google Scholar
• Zheng X-X, Zhou T, Wang X-A, et al. Histone deacetylases and atherosclerosis. Atherosclerosis. 2015;240(2):355–366.
   PubMed Web of Science ®Google Scholar
• Gillette TG, Hill JA. Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circ Res. 2015;116(7):1245–1253.
   PubMed Web of Science ®Google Scholar
• Tian W, Xu Y. Decoding liver injury: a regulatory role for histone modifications. Int J Biochem Cell Biol. 2015;67:188–193.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Pro B, Prince HM, et al. results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy. J Clin Oncol. 2012;30(6):631–636.
   PubMed Web of Science ®Google Scholar
• Duvic M, Talpur R, Ni X, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2006;109(1):31–39.
   PubMed Web of Science ®Google Scholar
• Ganai SA, Ramadoss M, Mahadevan V. Histone deacetylase (HDAC) inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration. Curr Neuropharmacol. 2016;14(1):55–71.
   PubMed Web of Science ®Google Scholar
• Eyupoglu IY, Savaskan NE. Epigenetics in brain tumors: HDACs take center stage. Curr Neuropharmacol. 2016;14(1):48–54.
   PubMed Web of Science ®Google Scholar
• Wagner JM, Hackanson B, Lübbert M, et al. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics. 2010;1(3–4):117–136.
   PubMedGoogle Scholar
• Munteanu B, Meyer B, Von Reitzenstein C, et al. Label-free in situ monitoring of histone deacetylase drug target engagement by matrix-assisted laser desorption ionization-mass spectrometry biotyping and imaging. Anal Chem. 2014;86(10):4642–4647.
   PubMed Web of Science ®Google Scholar
• Nishikori S, Hattori T, Fuchs SM, et al. Broad ranges of affinity and specificity of anti-histone antibodies revealed by a quantitative peptide immunoprecipitation assay. J Mol Biol. 2012;424(5):391–399.
   PubMed Web of Science ®Google Scholar
• Rothbart SB, Lin S, Britton L-M, et al. Poly-acetylated chromatin signatures are preferred epitopes for site-specific histone H4 acetyl antibodies. Sci Rep. 2012;2:489.
   PubMed Web of Science ®Google Scholar
• Egelhofer TA, Minoda A, Klugman S, et al. An assessment of histone-modification antibody quality. Nat Struct Mol Biol. 2011;18(1):91–93.
   PubMed Web of Science ®Google Scholar
• Britton L-MP, Gonzales-Cope M, Zee BM, et al. Breaking the histone code with quantitative mass spectrometry. Expert Rev Proteomics. 2011;8(5):631–643.
   PubMed Web of Science ®Google Scholar
• Villar-Garea A, Israel L, Imhof A. Analysis of histone modifications by mass spectrometry. In: Current protocols in protein science. John Wiley & Sons, Inc.; 2001. doi:10.1002/0471140864.ps1410s51.
   Google Scholar
• Aichler M, Walch A. MALDI imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest. 2015;95(4):422–431.
   PubMed Web of Science ®Google Scholar
• Thavarajah R, Mudimbaimannar VK, Elizabeth J, et al. Chemical and physical basics of routine formaldehyde fixation. J Oral Maxillofac Pathol. 2012;16(3):400–405.
   PubMedGoogle Scholar
• Chaurand P, Latham JC, Lane KB, et al. imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation. J Proteome Res. 2008;7(8):3543–3555.
   PubMed Web of Science ®Google Scholar
• Ergin B, Meding S, Langer R, et al. Proteomic analysis of PAXgene-fixed tissues. J Proteome Res. 2010;9(10):5188–5196.
   PubMed Web of Science ®Google Scholar
• Seeley E, Oppenheimer S, Mi D, et al. Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J Am Soc Mass Spectrom. 2008;19(8):1069–1077.
   PubMed Web of Science ®Google Scholar
• Franck J, Longuespee R, Wisztorski M, et al. MALDI mass spectrometry imaging of proteins exceeding 30,000 Da. Med Sci Monit. 2010;16:BR293−BR299.
   PubMed Web of Science ®Google Scholar
• Martin-Lorenzo M, Balluff B, Sanz-Maroto A, et al. 30mum spatial resolution protein MALDI MSI: in-depth comparison of five sample preparation protocols applied to human healthy and atherosclerotic arteries. J Proteomics. 2014;108:465–468.
   PubMed Web of Science ®Google Scholar
• van Remoortere A, van Zeijl RJ, van den Oever N, et al. MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom. 2010;21(11):1922–1929.
   PubMed Web of Science ®Google Scholar
• Grey AC, Chaurand P, Caprioli RM, et al. MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue. J Proteome Res. 2009;8(7):3278–3283.
   PubMed Web of Science ®Google Scholar
• Schey KL, Gutierrez DB, Wang Z, et al. Novel fatty acid acylation of lens integral membrane protein aquaporin-0. Biochemistry. 2010;49(45):9858–9865.
   PubMed Web of Science ®Google Scholar
• Wenke JL, Rose KL, Spraggins JM, et al. MALDI imaging mass spectrometry spatially maps age-related deamidation and truncation of human lens aquaporin-0MALDI imaging mass spectrometry. Invest Ophthalmol Vis Sci. 2015;56(12):7398–7405.
   PubMed Web of Science ®Google Scholar
• Deutskens F, Yang J, Caprioli RM. High spatial resolution imaging mass spectrometry and classical histology on a single tissue section. J Mass Spectrom. 2011;46(6):568–571.
   PubMed Web of Science ®Google Scholar
• Yang J, Caprioli RM. Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Anal Chem. 2011;83(14):5728–5734.
   PubMed Web of Science ®Google Scholar
• Van de Plas R, Yang J, Spraggins J, et al. Image fusion of mass spectrometry and microscopy: a multimodality paradigm for molecular tissue mapping. Nat Methods. 2015;12(4):366–372.
   PubMed Web of Science ®Google Scholar
• Hardesty WM, Kelley MC, Mi D, et al. Protein signatures for survival and recurrence in metastatic melanoma. J Proteomics. 2011;74(7):1002–1014.
   PubMed Web of Science ®Google Scholar
• Balluff B, Rauser S, Meding S, et al. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol. 2011;179(6):2720–2729.
   PubMed Web of Science ®Google Scholar
• Elsner M, Rauser S, Maier S, et al. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett’s adenocarcinoma. J Proteomics. 2012;75(15):4693–4704.
   PubMed Web of Science ®Google Scholar
• Grüner BM, Hahne H, Mazur PK, et al. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS ONE. 2012;7(6):e39424.
   PubMed Web of Science ®Google Scholar
• Meding S, Balluff B, Elsner M, et al. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J Pathol. 2012;228(4):459–470.
   PubMed Web of Science ®Google Scholar
• Le Faouder J, Laouirem S, Chapelle M, et al. Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J Proteome Res. 2011;10(8):3755–3765.
   PubMed Web of Science ®Google Scholar
• Min K-W, Bang J-Y, Kim KP, et al. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins. J Korean Med Sci. 2014;29(7):934–940.
   PubMed Web of Science ®Google Scholar
• Rebours V, Le Faouder J, Laouirem S, et al. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms. Pancreatology. 2014;14(2):117–124.
   PubMed Web of Science ®Google Scholar
• Poté N, Alexandrov T, Le Faouder J, et al. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas. Hepatology. 2013;58(3):983–994.
   PubMed Web of Science ®Google Scholar
• Chan Hyun N, Ji Hye H, Wan Sup K, et al. Identification of protein markers specific for papillary renal cell carcinoma using imaging mass spectrometry. Mol Cells. 2015;38(7):624–629.
   PubMed Web of Science ®Google Scholar
• Kriegsmann J, Kriegsmann M, Casadonte R. MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (Review). Int J Oncol. 2015;46:893–906.
   PubMed Web of Science ®Google Scholar
• Lagarrigue M, Alexandrov T, Dieuset G, et al. New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy. J Proteome Res. 2012;11(11):5453–5463.
   PubMed Web of Science ®Google Scholar
• Peffers MJ, Cillero-Pastor B, Eijkel GB, et al. Matrix assisted laser desorption ionization mass spectrometry imaging identifies markers of ageing and osteoarthritic cartilage. Arthritis Res Ther. 2014;16(3):R110.
   PubMed Web of Science ®Google Scholar
• Hanrieder J, Wicher G, Bergquist J, et al. MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue. Anal Bioanal Chem. 2011;401(1):135–147.
   PubMed Web of Science ®Google Scholar
• Morita Y, Ikegami K, Goto-Inoue N, et al. Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. Cancer Sci. 2010;101(1):267–273.
   PubMed Web of Science ®Google Scholar
• Li H, Hummon AB. Imaging mass spectrometry of three-dimensional cell culture systems. Anal Chem. 2011;83(22):8794–8801.
   PubMed Web of Science ®Google Scholar
• Djidja M-C, Francese S, Loadman PM, et al. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics. 2009;9(10):2750–2763.
   PubMed Web of Science ®Google Scholar
• LeRoy G, DiMaggio PA, Chan EY, et al. A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics Chromatin. 2013;6:20–20.
   PubMed Web of Science ®Google Scholar
• Lahiri S, Sun N, Solis-Mezarino V, et al. In situ detection of histone variants and modifications in mouse brain using imaging mass spectrometry. Proteomics. 2015 Nov 23. doi:10.1002/pmic.201500345. [Epub ahead of print].
   PubMedGoogle Scholar
• Maier SK, Hahne H, Gholami AM, et al. Comprehensive identification of proteins from MALDI imaging. Mol Cell Proteomics. 2013;12(10):2901–2910.
   PubMed Web of Science ®Google Scholar
• Spraggins JM, Rizzo DG, Moore JL, et al. MALDI FTICR IMS of intact proteins: using mass accuracy to link protein images with proteomics data. J Am Soc Mass Spectrom. 2015;26(6):974–985.
   PubMed Web of Science ®Google Scholar
• Balluff B, Frese CK, Maier SK, et al. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. J Pathol. 2015;235(1):3–13.
   PubMed Web of Science ®Google Scholar
• Rompp A, Spengler B. Mass spectrometry imaging with high resolution in mass and space. Histochem Cell Biol. 2013;139(6):759–783.
   PubMed Web of Science ®Google Scholar